Physician profile
Alejandro Blachar
NPI 1245208206
$1,577.94
in general payments reported to CMS, 2019-2025
18 companies · $316 in 2025
The $316 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $467 · 2020: $35.27 · 2021: $40.82 · 2022: $45.18 · 2023: $37.53 · 2024: $636 · 2025: $316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $990.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $989.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Protega Pharmaceutials INC | $533.55 | 2024-2025 | Roxybond |
| Nevro Corp. | $180.77 | 2019-2024 | Senza |
| Tersera Therapeutics LLC | $178.55 | 2019 | |
| Collegium Pharmaceutical, INC. | $106.40 | 2019-2025 | Belbuca, Xtampza |
| Globus Medical, INC. | $86.10 | 2025 | Senza |
| Scilex Pharmaceuticals INC. | $76.98 | 2019-2025 | |
| Abbott Laboratories | $72.55 | 2019-2025 | Eterna |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $68.74 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $60.27 | 2019 | |
| Medtronic, INC. | $55.10 | 2021-2025 | Inceptiv |
| Lundbeck LLC | $39.53 | 2024 | Rexulti |
| Vanda Pharmaceuticals INC. | $34.70 | 2024 | Fanapt, Hetlioz |
| Vertex Pharmaceuticals Incorporated | $17.96 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $16.71 | 2024 | Uzedy |
| Horizon Therapeutics Plc | $14.09 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $13.07 | 2019 | |
| Medtronic USA, INC. | $11.73 | 2020 | |
| Pfizer INC. | $11.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alejandro Blachar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.